華融化學(301256.SZ):2023年度淨利潤預增10.52%-18.71%
格隆匯1月18日丨華融化學(301256.SZ)公佈2023年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利13,500萬元-14,500萬元,比上年同期增長10.52%-18.71%;扣除非經常損益後的淨利潤盈利9,800萬元-10,500萬元,比上年同期增長1.51%-8.76%。
業績變動原因:1、報吿期內,在氫氧化鉀價格下行的過程中,公司實施盡產盡銷策略,氫氧化鉀產銷量同比增加,期末產品庫存同比下降;公司優化採購方式,氯化鉀實際單位成本同比大幅降低,實際單位毛利大幅增加;因此公司實際毛利大幅增加。
2、2022年,公司出口業務量價齊升,出口收入大幅增長,公司持有美元外匯增加並持有至報吿期內,同時受美元兑人民幣匯率升值以及美元存款利率上升的共同影響,故公司匯兑收益及美元利息收入同比增加。
3、2022年3月,公司首次公開發行股票募集資金到賬。對比上年同期,報吿期內閒置自有資金和閒置募集資金增加,因此現金管理收益增加。
4、非經常性損益金額約為3,700-4,000萬元,同比增加約1,139-1,439萬元,主要系現金管理收益同比增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.